Genfit - Company & Market Research Reports

GENFIT is a biopharmaceutical company that focuses on developing diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Its lead pipeline product elafibranor (GFT505) has recently completed a positive Phase 2b study in NASH (Non-Alcoholic Steato-Hepatitis). Genfit SA was founded in 1999 and is headquartered in Loos, France.

NASH (Non-alcoholic Steatohepatitis) biomarkers - Global Market Outlook (2017-2023) - Product Thumbnail Image

NASH (Non-alcoholic Steatohepatitis) biomarkers - Global Market Outlook (2017-2023)

  • Report
  • 185 Pages
From
NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis By Type, By End-Use (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis By Type, By End-Use (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes), And Segment Forecasts, 2014 - 2025

  • Report
  • 100 Pages
From
Global Nonalcoholic Steatohepatitis Therapeutics and Diagnostics Market - Segmented by Pipeline Therapeutics, Diagnostic Techniques, Treatment Therapies, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Global Nonalcoholic Steatohepatitis Therapeutics and Diagnostics Market - Segmented by Pipeline Therapeutics, Diagnostic Techniques, Treatment Therapies, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 108 Pages
From
Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018

  • Report
  • 159 Pages
From
2018 Gastritis (stomach inflammation) Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Gastritis (stomach inflammation) Drug Development- Pipeline Analysis Report

  • Report
  • 40 Pages
From
Nonalcoholic Steatohepatitis (NASH): Update Bulletin - Product Thumbnail Image

Nonalcoholic Steatohepatitis (NASH): Update Bulletin

  • Newsletter
From
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Report
  • 344 Pages
From
Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in Development, Regulatory Guidelines and Market Opportunity in Various Geographies - Product Thumbnail Image

Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in Development, Regulatory Guidelines and Market Opportunity in Various Geographies

  • Report
  • 65 Pages
From
Global Non-Alcoholic Steatohepatitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026 - Product Thumbnail Image

Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026

  • Report
  • 197 Pages
From
Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022)  - Product Thumbnail Image

Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022)

  • Report
  • 210 Pages
From
Psoriasis - Pipeline Review, H2 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 726 Pages
From
Psoriasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 709 Pages
From
NASH Drugs Market, 2015 - 2025 - Product Thumbnail Image

NASH Drugs Market, 2015 - 2025

  • Report
  • 188 Pages
From
Inflammatory Bowel Disease - Pipeline Review, H2 2015 - Product Thumbnail Image

Inflammatory Bowel Disease - Pipeline Review, H2 2015

  • Drug Pipelines
  • 1025 Pages
From
Non-Alcoholic Steatohepatitis (NASH) Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 277 Pages
From
Global NASH (Non-Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) (By Region, By Drugs - Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market) - Product Thumbnail Image

Global NASH (Non-Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) (By Region, By Drugs - Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market)

  • Report
  • 112 Pages
From
Non-Alcoholic Steatohepatitis Market by Drug Type, and Sales Channel - Global Opportunity Analysis and Industry Forecast, 2021-2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market by Drug Type, and Sales Channel - Global Opportunity Analysis and Industry Forecast, 2021-2025

  • Report
  • 155 Pages
From
Global Non-alcoholic Steatohepatitis Market - by Drug Type, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023) - Product Thumbnail Image

Global Non-alcoholic Steatohepatitis Market - by Drug Type, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)

  • Report
  • 122 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Loading Indicator
adroll